OUL35

CAS No. 6336-34-1

OUL35( NSC39047 )

Catalog No. M24643 CAS No. 6336-34-1

OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 47 In Stock
10MG 77 In Stock
25MG 149 In Stock
50MG 237 In Stock
100MG 368 In Stock
500MG 872 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    OUL35
  • Note
    Research use only, not for human use.
  • Brief Description
    OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.
  • Description
    OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC39047
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    ARTD10|PARP10
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6336-34-1
  • Formula Weight
    256.26
  • Molecular Formula
    C14H12N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C1=CC(=CC=C1C(=O)N)OC2=CC=C(C=C2)C(=O)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tripathi P , Tian Y M , Komnig D . The mono-ADP-ribosyltransferase ARTD10 regulates the voltage-gated K+ channel Kv1.1 through protein kinase C delta[J]. BMC Biology, 2020.
molnova catalog
related products
  • RBN-2397

    RBN-2397 (0.0001-100 μM; 24 hours) inhibits cells proliferation with an IC50 value of 20 nM in NCI-H1373 lung cancer cells.

  • E7016

    E7016 (GPI 21016) is an orally available PARP inhibitor that inhibits DNA repair and enhances tumor cell radiosensitivity both in vitro and in vivo.

  • Talazoparib tosylate

    Talazoparib tosylate is a novel and potent PARP1/2 (n IC50: 0.57 nM for PARP1).